.
MergerLinks Header Logo

New Deal


Announced

TA Associates to acquire a minority stake in Diatech Pharmacogenetics from Alto Partners.

Synopsis

TA Associates, a global private equity firm, agreed to acquire a minority stake in Diatech Pharmacogenetics, a pharmacogenetics and cancer precision medicine diagnostics company, from Alto Partners, a multi-family office. Financial terms were not disclosed. “Diatech’s comprehensive, market-leading product portfolio highlights the Company’s commitment to a rigorous and differentiated R&D process that consistently drives value creation. We look forward to partnering with Fabio, Oliva, and the entire management team to support Diatech’s international and domestic growth journey,” Lovisa Lander, TA Associates Director.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US